Clinical Trial Update: A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic Nephropathy [NA]

View source ↗

Summary

This trial update reports the termination of a proof-of-concept study evaluating darbepoetin alfa for partial correction of anemia in Chinese patients with diab…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Diabetes Mellitus, Chronic Kidney Disease | NA | Status: TERMINATED